Since its founding in 1955, Advanced Instruments has been dedicated to increasing productivity and ensuring quality in the biotechnology, pharmaceutical, clinical and food & beverage industries. The company designs and commercializes systems that help their global customer base improve product quality and safety, meet regulatory requirements, and reduce costs. Advanced Instruments is known globally for its commitment to customer-centric innovation, exceptional product quality, and comprehensive customer support.
Advanced Instruments has entrenched osmolality as a critical and high-value test enabling the rapid and cost-effective diagnosis of medical conditions and assessment of product quality in a variety of settings. The company has built a strong brand reputation and deep customer relationships, it is recognized as the global authority on osmolality testing, and its products are the standard within each of its core clinical, biopharmaceutical, and food & beverage markets.
Patricia Industries acquired Advanced Instruments in October 2020 and owns 98% of the company, with members of the management team and Board owning the remainder. The company is headquartered in Norwood, Massachusetts.
Key for future value creation
• The key near-term focus is on continuing to add to the company’s human capital, expanding direct commercial capabilities globally, and accelerating investment in the new product pipeline - as well as evaluating additional acquisition targets within both the biopharmaceutical and clinical markets.
• There are multiple organic and non-organic opportunities for long-term profitable growth due to strong and durable underlying growth rates in each of the company’s core markets, as well as a diverse array of strategic acquisition targets within each of Advanced Instruments’ core markets.
|
Patricia Industries ownership (capital/votes): 99/99 |